Adagio Medical ADGM
- Market cap
- $2.3M
- PE
- n/m
- a loss over the last year
- Forward PE
- n/m
- not a meaningful number
- Price to sales
- n/a
- EV/EBIT
- n/m
- a loss over the last year
- Revenue, 12 months
- $0
- Net margin
- n/a
- Free cash flow yield
- −727.1%
Adagio Medical's trailing earnings are negative, so it has no PE. Revenue was $0 over the last twelve months.
Charts
Financials
| Income statement | Q3 FY23 | Q4 FY23 | Q1 FY24 | Q2 FY24 | Q1 FY25 | Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 |
|---|---|---|---|---|---|---|---|---|---|---|
| $41K | $78K | $26K | $254K | $0 | $0 | $0 | $0 | $0 | $0 | |
| Cost of revenue | $253K | $334K | $542K | $682K | $253K | $342K | $31K | $58K | n/a | n/a |
| Gross profit | −$212K | −$256K | −$516K | −$428K | −$253K | −$342K | −$31K | −$58K | n/a | n/a |
| R&D | $4.4M | $1.8M | $3.5M | $2.9M | $3.7M | $2M | $2.8M | $2.2M | $2.7M−25% | $2.5M+24% |
| SG&A | $4.5M | $3.3M | $4.8M | $3.4M | $3.5M | $2.4M | $2.9M | $1.7M | $2.5M−29% | $2.5M+3% |
| −$9.1M | −$5.3M | −$8.8M | −$6.7M | −$7.4M | −$4.7M | −$5.7M | −$4M | −$5.2M−30% | −$4.9M+5% | |
| Interest expense | $485K | $577K | $754K | $760K | $662K | $720K | $749K | $775K | $778K+18% | $805K+12% |
| Net income | −$10.8M | −$8.6M | −$8M | −$5.7M | −$7.7M | −$3.9M | −$10.1M | −$3.3M | −$7M−9% | −$6.7M+70% |
| −$14.15 | n/a | −$10.28 | −$7.35 | −$0.51 | −$0.35 | −$0.66 | −$0.16 | −$0.31−39% | −$0.30−14% | |
| n/a | n/a | 779.9K | 779.9K | 15.4M | 15.4M | 15.4M | 20.1M | 22.2M+45% | 22.2M+44% |
Gross profit: 8 periods, Q3 FY23 to Q4 FY25: not printed by the filing, worked out from its own lines.
Net income: Q4 FY25: not printed by the filing, worked out from its own lines.
EPS, diluted: Q4 FY25: quarter's net income to common over its shares, to the cent.
Diluted shares: Q1 FY24: share-days: the 6-month average less the second quarter's. Q4 FY25: a loss quarter: its basic count, share-days: the 12-month average less the 9-month, weighted by days.
From each company's 10-Q and 10-K filings, the newest version of each figure. Quarters are as filed (a fourth quarter is the year less its first nine months), fiscal years as the 10-K prints them, restated where a later 10-K restated them, and balance sheet lines as of the period's end. A quarter whose 10-Q isn't filed yet is from the company's results release. Growth is on the same period a year earlier. A dash is a period with no figure for the line: the filing doesn't print it, or it hasn't been read yet.
Peers
Companies in Healthcare nearest Adagio Medical's size, closest first.
| Company | Market cap | PE | Its 10y median PE | Fwd PE | P/S | Revenue growth | Net margin |
|---|---|---|---|---|---|---|---|
| ADGMAdagio Medical | $2.3M | n/m | n/a | n/a | n/m | n/a | |
| OXBROXBRIDGE RE HOLDINGS | $7.7M | 47.5× | 9.6× | 2.8× | +40% | 4.7% | |
| EDUCEducational Development | $8.7M | 5.4× | 11.3× | 0.4× | −32% | 8.6% | |
| GTIMGood Times Restaurants | $13.6M | 6.1× | 13.6× | 0.1× | −6% | 1.7% | |
| MDRRMedalist Diversified | $15.4M | 2.5× | 3.0× | 1.6× | −1% | 80.2% | |
| BCGBinah Capital | $18.2M | 6.7× | 20.8× | 0.1× | +8% | 2.2% | |
| VIPVulcan Infrastructure & Power | $19.6M | 17.9× | 24.4× | 0.4× | −14% | 1.0% | |
| MXCMexco Energy | $20.5M | 13.4× | 13.3× | 3.0× | −9% | 23.3% | |
| CKXCKX Lands | $21.5M | 7.4× | 32.6× | 31.0× | −17% | n/m | |
| MSGMMotorsport Games | $22.5M | 11.4× | 11.5× | 1.5× | +79% | 16.2% | |
| Peer median | $18.2M | 7.4× | 13.3× | 1.5× | −6% | 6.7% |
More on Adagio Medical
Each number over time
Its groups
About
- Industry
- Medical - Instruments & Supplies
- Sector
- Healthcare
Valuation data, not investment advice. Prices as of .